Mangrove Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$78.4M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$61.9M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$31.4M |
| 4 |
Tower Semiconductor
TSEM
|
+$21.2M |
| 5 |
AMED
Amedisys
AMED
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TXNM
TXNM Energy Inc
TXNM
|
+$30.5M |
| 2 |
Alibaba
BABA
|
+$27.4M |
| 3 |
CNH
CNH Industrial
CNH
|
+$21.2M |
| 4 |
Bath & Body Works
BBWI
|
+$18.8M |
| 5 |
Turning Point Brands
TPB
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 11.53% |
| 2 | Financials | 11.37% |
| 3 | Technology | 8.8% |
| 4 | Healthcare | 8.62% |
| 5 | Industrials | 7.63% |
Similar funds
Mangrove Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Mangrove Partners held 209 positions worth $1.48B, up 12% from $1.33B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Mangrove Partners deployed $58.7M of net new capital in Q4 2023, opening 42 new positions and adding to 18 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 813,521 shares worth $88.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, down from 15% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Turning Point Brands, an estimated $17.3M trimmed.
- Mangrove Partners's largest Q4 2023 buy was iShares Core S&P Small-Cap ETF: 813,521 shares worth $88.1M.
- Mangrove Partners added most to Liberty Live Group Series C in Q4 2023, an estimated $10.6M increase.
- Mangrove Partners's biggest Q4 2023 reduction was Turning Point Brands, cutting an estimated $17.3M.
- Mangrove Partners fully exited TXNM Energy Inc in Q4 2023, selling an estimated $30.5M.
- Mangrove Partners's ten largest holdings make up 31% of its $1.48B portfolio in Q4 2023.
- Mangrove Partners opened 42 new positions and closed 33 in Q4 2023.
- Mangrove Partners's portfolio value rose 12% quarter-over-quarter to $1.48B.
Based on Mangrove Partners's 13F filing for Q4 2023, filed 14 Feb 2024.